Q-Linea
3,975 SEK +0,51%1 investor følger denne virksomhed
Q-Linea is active in medical technology. The company specializes in the research and development of instruments and consumables. The products are mainly used in the treatment of infectious diseases and blood poisoning and include diagnostic and analysis tools, as well as other related basic sample handlings. The technology is based on the so-called ID and AST technology. The company was founded in 2008 and is headquartered in Uppsala.
Omsætning
4,44 mio.
EBIT %
-5.193,47 %
P/E
-
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
NASDAQ Stockholm
QLINEA
Daglig lav / høj pris
3,615 / 4,2
SEK
Markedsværdi
465,74 mio. SEK
Aktieomsætning
2,13 mio. SEK
Volumen
531 t
Seneste videoer
Finanskalender
Delårsrapport
11.07.2024
Delårsrapport
31.10.2024
Større aktionærerKilde: Millistream Market Data AB
Ejer | Kapital | Stemmer |
---|---|---|
Nexttobe AB | 53,5 % | 53,5 % |
Fjärde AP-fonden | 8,0 % | 8,0 % |
Premium
This content is for our Premium customers only.
ViserAlle indholdstyper
BULLETIN FROM ANNUAL GENERAL MEETING IN Q-LINEA AB (PUBL)
Q-linea announces shipment of first IVD-marked ASTar® instrument to the US
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools